Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+52Cutaneous Melanoma+24Malignant Laryngeal Neoplasm+24Malignant Bladder Neoplasm+20Malignant Esophageal Neoplasm+12Malignant Pancreatic Neoplasm+12Malignant Prostate Neoplasm+12Malignant Salivary Gland Neop…+12Malignant Kidney Neoplasm+8Malignant Mesothelioma+8Malignant Testicular Neoplasm+8Malignant Liver Neoplasm0Malignant Lung Neoplasm0Malignant Penile Neoplasm0Malignant Thyroid Gland Neopl…0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+52100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21787
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
92
activityPercentile
40

ranking row 2597256

2=Cutaneous Melanoma+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5672
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
48
activityPercentile
24

ranking row 2597257

2=Malignant Laryngeal Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2949
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
16

ranking row 2597258

4=Malignant Bladder Neoplasm+2088Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9791
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
68
activityPercentile
48

ranking row 2597259

5=Malignant Esophageal Neoplasm+1284Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10847
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
72
activityPercentile
60

ranking row 2597260

5=Malignant Pancreatic Neoplasm+1284Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
17515
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
88
activityPercentile
76

ranking row 2597261

5=Malignant Prostate Neoplasm+1284Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
28471
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
96
activityPercentile
84

ranking row 2597263

5=Malignant Salivary Gland Neoplasm+1284Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
474
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
24
activityPercentile
12

ranking row 2597262

9=Malignant Kidney Neoplasm+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8206
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
64
activityPercentile
56

ranking row 2597265

9=Malignant Mesothelioma+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2010
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
36
activityPercentile
28

ranking row 2597264

9=Malignant Testicular Neoplasm+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
358
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
12
activityPercentile
4

ranking row 2597266

12=Malignant Liver Neoplasm056Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12302
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
80
activityPercentile
80

ranking row 2597268

12=Malignant Lung Neoplasm056Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
88541
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2597267

12=Malignant Penile Neoplasm056Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
246
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
4
activityPercentile
4

ranking row 2597270

12=Malignant Thyroid Gland Neoplasm056Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
687
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
32
activityPercentile
32

ranking row 2597269

16=Leukemia-440Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12758
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
84
activityPercentile
88

ranking row 2597271

17=Hodgkin Lymphoma-836Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
639
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
28
activityPercentile
36

ranking row 2597272

17=Malignant Gastric Neoplasm-836Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6735
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
56
activityPercentile
64

ranking row 2597273

17=Malignant Hypopharyngeal Neoplasm-836Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
223
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
0
activityPercentile
8

ranking row 2597274

17=Malignant Rectal Neoplasm-836Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5146
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
44
activityPercentile
52

ranking row 2597275

21=Malignant Anal Neoplasm-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
274
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
8
activityPercentile
20

ranking row 2597277

21=Malignant Central Nervous System Neoplasm-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7686
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
60
activityPercentile
72

ranking row 2597276

23=Multiple Myeloma-1612Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5819
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
52
activityPercentile
68

ranking row 2597278

23=Non-Hodgkin Lymphoma-1612Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11003
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
76
activityPercentile
92

ranking row 2597279

25=Malignant Nasopharyngeal Neoplasm-284Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
436
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
16
activityPercentile
44

ranking row 2597280

26=Malignant Breast Neoplasm-760Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
437
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
20
activityPercentile
96

ranking row 2597281

Data updated 16 hours agoSource updated unknown26 eligible entities · inputs hash 30bd8ef88d8328da43062de6